ADMA BIOLOGICS, INC. (ADMA)
About ADMA BIOLOGICS, INC.
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $510.2M
- Net income
- $146.9M
- Total assets
- $624.2M
- Market cap
- $1.9B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.9B
- Shares outstanding
- 179.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 17, 2013
Adma Biologics, Inc. (ADMA) Stock Price
- Profitable — net income of $146.9M in FY2025.
- Trading 48% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review ADMA BIOLOGICS, INC..
Write a review
News about ADMA BIOLOGICS, INC.
News & sentiment via Polygon.io
Adma Biologics, Inc.: frequently asked questions
Is Adma Biologics, Inc. an American company?
Adma Biologics, Inc. is a US-based company headquartered in Ramsey, New Jersey, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Adma Biologics, Inc. headquartered?
Adma Biologics, Inc. is headquartered in Ramsey, New Jersey, United States.
Is Adma Biologics, Inc. publicly traded?
Yes — Adma Biologics, Inc. is a publicly traded company. Its stock trades under the ticker symbol ADMA on the NASDAQ.
What does Adma Biologics, Inc. do?
Adma Biologics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
